<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77315">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02015845</url>
  </required_header>
  <id_info>
    <org_study_id>2013/19</org_study_id>
    <nct_id>NCT02015845</nct_id>
  </id_info>
  <brief_title>Evaluation of Accuvein in Obese Patients</brief_title>
  <official_title>Evaluation of Accuvein in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the effectiveness of Accuvein to facilitate
      placement of peripheral intravenous catheters in obese patients. This clinical protocol is
      designed to determine whether using Accuvein increases the ease and efficiency of venous
      cannulation (as perceived by the operator), decreases the time to effective cannulation, and
      decreases the patient's perception of the pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Percentage of success of the first vein puncture</measure>
    <time_frame>one hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Successful successful placement of IV catheter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score of evaluation of the device</measure>
    <time_frame>one hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of the device by the operator and the patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Primary Care</condition>
  <arm_group>
    <arm_group_label>Accuvein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Accuvein to facilitate placement of peripheral intravenous catheters in obese patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Routine technique used to insert a peripheral intravenous catheters in obese patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Accuvein</intervention_name>
    <arm_group_label>Accuvein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Routine technique</intervention_name>
    <description>Placement of peripheral intravenous catheters using the routine technique</description>
    <arm_group_label>Routine technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obese adults ( BMI equal or greater 35) requiring a venous blood sampling or the
             placement of a venous peripheral catheter

        Exclusion Criteria:

          -  pregnant woman
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Fischler, MD</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Hospitalier Franco-Britannique</name>
      <address>
        <city>Levallois-Perret</city>
        <state>Hauts de Seine</state>
        <zip>92300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Solier, MD</last_name>
      <phone>47 59 59 59</phone>
      <phone_ext>00331</phone_ext>
      <email>marc.solier@ihfb.org</email>
    </contact>
    <investigator>
      <last_name>Marc Solier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Hauts de Seine</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD</last_name>
      <phone>46252442</phone>
      <phone_ext>00331</phone_ext>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Marc Fischler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de la Baie des Citrons</name>
      <address>
        <city>Nouméa</city>
        <state>Nouvelle-Calédonie</state>
        <zip>98845</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Charmeau, MD</last_name>
      <phone>33146252442</phone>
    </contact>
    <investigator>
      <last_name>Alain Charmeau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 13, 2013</lastchanged_date>
  <firstreceived_date>December 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
